📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. (2021)

First Author: Zuo J

Attributed to: A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41590-021-00902-8

PubMed Identifier: 33674800

Publication URI: http://europepmc.org/abstract/MED/33674800

Type: Journal Article/Review

Volume: 22

Parent Publication: Nature immunology

Issue: 5

ISSN: 1529-2908